(HealthDay)-The use of heterologous ChAdOx1 nCoV-19 and mRNA prime boost vaccinations is more effective than allogeneic ChAdOx1 nCoV-19 / ChAdOx1 nCoV-19 prime boost vaccinations. Lancet Regional Health: Europe..
Peter Nordström, MD, Ph.D. from Umeå University, Sweden. We investigated the efficacy of heterologous prime boost COVID-19 vaccination in Swedish individuals who received two doses of COVID-19. vaccination The study cohort included 94,569 people who received the heterologous ChAdOx1 nCoV-19 / BNT162b2 prime boost vaccination, 16,402 people who received the ChAdOx1 nCoV-19 / mRNA-1273 prime boost vaccination, and 430,100 people who received the allogeneic ChAdOx1. It was. nCoV-19 / ChAdOx1 nCoV-19 Prime Boost Vaccination. In addition, 180,716 individuals who were not vaccinated on the date of vaccination of the corresponding cases were selected.
Researchers found that 187 patients on a heterologous vaccine schedule (incidence, 2.0 / 100,000 man-days) and 306 patients in an unvaccinated control group (incidence, 7.1 per 100,000 man-days) were symptomatic during an average follow-up period. COVID-19 infection was confirmed. -Until 76 days. Adjusted vaccine efficacy was 67% and 79% for heterologous ChAdOx1 nCoV-19 / BNT162b2 prime boost vaccination and heterologous ChAdOx1 nCoV-19 / mRNA-1273 prime boost vaccination, respectively. When analyzed in combination, the vaccine efficacy of the heterologous schedule was 68%, significantly higher than 50%. effect It is found in the same species of ChAdOx1nCoV-19 vaccination.
“our study Nordstrom said in a statement that those who received the vector-based vaccine first had a significantly lower risk for those who received the mRNA vaccine than those who received the vector-based vaccine at both doses. Is shown.
Summary / Full text
Copyright © 2021 HealthDay.. all rights reserved.
Quote: A more effective booster for the mRNA vaccine against ChAdOx1 nCoV-19 (2021, October 22) is from https://medicalxpress.com/news/2021-10-mrna-vaccine-effective-booster-chadox1.html Acquired on October 22, 2021
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
A more effective booster than the mRNA vaccine for ChAdOx1nCoV-19
Source link A more effective booster than the mRNA vaccine for ChAdOx1nCoV-19